Marinomed Biotech financials at a glance

The revenue of Marinomed Biotech is reported as 0.00918 billion Euro in the fiscal year 2023. The earnings were -4.5 Euro per share in 2023, which was 7.5 lower than 2021. And about -0.00341 billion Euro are reported as free cash flow in the financials of Marinomed Biotech 2023. No dividends were paid to the shareholders of the Marinomed Biotech stock WBAG:MARI in the financial year 2023.